WASHINGTON—ProSolv CardioVascular, a Fujifilm Medical Systems’ company, is launching its ProSolv CardioVascular 4.0, a new web-based software application for full viewing and reporting capabilities using web communication protocols, secured via SSL, this week at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. The application can be downloaded and installed via a web URL.
The new version truly addresses needs for any-sized facility, allowing for the same DICOM image-quality and the same user interface of previous ProSolv version can now be accessed remotely, said Karen Bower, product manager.
“The accessibility for a physician to access the data from wherever he or she desires is a huge improvement. In our previous software versions, it was possible to access data remotely, but it required a hole in the firewall of the provider. Now, with the https web-based protocols, there are no such requirements, in order to access secure data remotely,” according to Aaron S. Waitz, president and CEO of ProSolv.
After collaboration with existing customers, the company learned that the web-based module allows for improved workflow because physicians can return home to their families, and then continue from working at their leisure, as opposed to being confined to a particular, specialized workstation in the hospital, Waitz elaborated.
Also, the module allows for full integration to Fujifilm’s Synapse PACS, which allows for access to the entire patient record—allowing for eventual widespread EMR adoption—so the physician is not confined the patient’s cardiovascular records, but also can access echo or a cath lab data, according to Bower.
Despite the web-based capabilities of Version 4.0, the provider still owns and maintains its data, which can migrated into either the Synapse or another vendor’s PACS, she said.
Another works-in-progress that ProSolv is displaying at TCT is its ECG module, which is not expected to be released until the end of the month. It will allow for further access to patient data for the physician, allowing for the most informed decision-making, according to Waitz.
He concluded that the key to many of the accreditation and certification issues are the proper aggregation of data. “If a facility wants to receive accreditation, it must be able to collect data. However, providers can utilize considerable of time and man power, in order to access data, such as cross-correlation studies—all of which is pulled automatically from all modalities according to the customizable needs of the provider with the new ProSolv Cardiovascular version,” he said.